Dextrose (Hospira, Inc.)


Welcome to the PulseAid listing for the Dextrose drug offered from Hospira, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Hospira, Inc.
NON-PROPRIETARY NAME: Dextrose monohydrate
SUBSTANCE NAME: DEXTROSE MONOHYDRATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2006-02-22
END MARKETING DATE: 0000-00-00


Dextrose HUMAN PRESCRIPTION DRUG Details:

Item DescriptionDextrose from Hospira, Inc.
LABELER NAME: Hospira, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 250(mg/mL)
START MARKETING DATE: 2006-02-22
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0409-1775_e3b8bf71-2e60-439f-8475-458d0b6aa900
PRODUCT NDC: 0409-1775
APPLICATION NUMBER: NDA019445

Other DEXTROSE MONOHYDRATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
B. Braun Medical Inc.Dextrose
Baxter Healthcare CorporationDEXTROSE
Becton Dickinson and CompanyDextrose
Cardinal HealthDEXTROSE
Fresenius Kabi USA, LLCDextrose
General Injectables & Vaccines, IncDextrose
General Injectables & Vaccines, Inc.Dextrose
Hospira, Inc.Dextrose
International Medication Systems, LimitedDextrose Monohydrate
Physicians Total Care, Inc.Dextrose